TOP STORIES
oncology
Adverse events

Reassurance on infection risk with checkpoint inhibitors


Rates of infection appear similar in patients with solid tumours before and after they receive immune checkpoint inhibitor (ICI) therapy. A retrospective study from the Canberra Hospital assessed infection rates in 327 patients who commenced ICIs between 2012 and 2019....

Rates of infection appear similar in patients with solid tumours before and after they receive immune checkpoint inhibitor (ICI) therapy. A...

Read more